117 SettembreC.Di MaltaC.PolitoV
Last reviewed: June 15, 2026 Last updated: June 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
This dual action, increasing fat breakdown while blocking fat formation, creates a metabolic environment that favors net fat loss even when caloric intake is not dramatically reduced
Furthermore, the heterogenous nature of ME/CFS associated with ME/CFS subtypes, severity, and duration, in addition to inconsistencies in cytokine methodologies and repeatability suggests that cytokine profiling as a quantitative diagnostic biomarker harbours a lot of limitations and may not ultimately be feasible
Still, straying too far from the recommended amount could lead to a variety of health issues
Contact [email protected] immediately if an address needs correction